CONCERT PHARMACEUTICALS, INC. 3,300,000 Shares of Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • March 19th, 2015 • Concert Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Each of the undersigned, Roger Tung, President and Chief Executive Officer of Concert Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Nancy Stuart, Chief Operating Officer of the Company, on behalf of the Company, does hereby certify pursuant to Section 6(i) of that certain Underwriting Agreement dated March 19, 2015 (the “Underwriting Agreement”) between the Company and, on behalf of the several Underwriters named therein, Wells Fargo Securities, LLC and JMP Securities LLC that as of [ ]
